Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GABAA receptor subtype involvement in addictive behaviour
David Stephens, Sarah L. King, Jeremy J. Lambert, et al.
Genes Brain & Behavior (2016) Vol. 16, Iss. 1, pp. 149-184
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

GABAA receptor subtypes and benzodiazepine use, misuse, and abuse
Elif Engin
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 33
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Milica Radosavljević, Dubravka Švob Štrac, Jasna Jančić, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 25
Established and emerging GABAA receptor pharmacotherapy for epilepsy
Robert J. Richardson, Steven Petrou, Alexander Bryson
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Single-nucleus genomics in outbred rats with divergent cocaine addiction-like behaviors reveals changes in amygdala GABAergic inhibition
Jessica Zhou, Giordano de Guglielmo, Aaron J. Ho, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 11, pp. 1868-1879
Open Access | Times Cited: 17
Decreased brain connectivity in smoking contrasts with increased connectivity in drinking
Wei Cheng, Edmund T. Rolls, Trevor W. Robbins, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 51
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine
María Scherma, Johanna S. Qvist, Arun Asok, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 18, pp. 9991-10002
Open Access | Times Cited: 47
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders
Autumn Walkerly, Lauren D. Leader, Emily Cooke, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3017-3026
Open Access | Times Cited: 41
Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness
Daniel C. Mograbi, Rafael Rodrigues, Bheatrix Bienemann, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 8, pp. 323-340
Open Access | Times Cited: 4
Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics
Nebojša Nick Knežević, Ajay Yekkirala, Tony L. Yaksh
Anesthesia & Analgesia (2017) Vol. 125, Iss. 5, pp. 1714-1732
Open Access | Times Cited: 37
Interactions of Fipronil within Fish and Insects: Experimental and Molecular Modeling Studies
Bo Zhang, Lei Zhang, Lujue He, et al.
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 23, pp. 5756-5761
Closed Access | Times Cited: 36
Changes of Neurotransmitters in Youth with Internet and Smartphone Addiction: A Comparison with Healthy Controls and Changes after Cognitive Behavioral Therapy
Hyung Suk Seo, Eun‐Kee Jeong, Sungwon Choi, et al.
American Journal of Neuroradiology (2020) Vol. 41, Iss. 7, pp. 1293-1301
Open Access | Times Cited: 28
Obesity alters the ovarian proteomic response to zearalenone exposure
María Estefanía González-Alvarez, Bailey C. McGuire, Aileen F. Keating
Biology of Reproduction (2021) Vol. 105, Iss. 1, pp. 278-289
Open Access | Times Cited: 27
Allopregnanolone Decreases Evoked Dopamine Release Differently in Rats by Sex and Estrous Stage
Ana Paula Segantine Dornellas, Giovana C. Macedo, Minna H. McFarland, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 25
Interaction of gonadal hormones, dopaminergic system, and epigenetic regulation in the generation of sex differences in substance use disorders: A systematic review
Raquel Santos‐Toscano, María‐Ángeles Arévalo, Luis Miguel García‐Segura, et al.
Frontiers in Neuroendocrinology (2023) Vol. 71, pp. 101085-101085
Open Access | Times Cited: 10
Early-life adversity selectively impairs α2-GABAA receptor expression in the mouse nucleus accumbens and influences the behavioral effects of cocaine
Scott J. Mitchell, Edward P. Maguire, Linda Cunningham, et al.
Neuropharmacology (2018) Vol. 141, pp. 98-112
Open Access | Times Cited: 30
Neuropharmacological potentials of β-carboline alkaloids for neuropsychiatric disorders
Yusuf Oloruntoyin Ayipo, Mohd Nizam Mordi, Muzaimi Mustapha, et al.
European Journal of Pharmacology (2020) Vol. 893, pp. 173837-173837
Closed Access | Times Cited: 25
Effect of alcohol on the sense of agency in healthy humans
Silvana De Pirro, Peter Lush, Jim Parkinson, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 23
The gabapentinoid drugs and their abuse potential
Aleyah E. Goins, Keisha Patel, Sascha R.A. Alles
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107926-107926
Closed Access | Times Cited: 20
Pronounced antiseizure activity of the subtype‐selective GABAA positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy
Rachel Gurrell, Philip Iredale, Alexis Evrard, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 11, pp. 1875-1882
Open Access | Times Cited: 13
Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience
M. Beaurain, Anne‐Sophie Salabert, Maria João Ribeiro, et al.
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 20
Mapping GABAergic projections that mediate feeding
Joshua Wang, Max O’Reilly, Ignatius Alvarez Cooper, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 163, pp. 105743-105743
Open Access | Times Cited: 2
Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors
Agnes Gasiorek, Sarah M. Trattnig, Philip K. Ahring, et al.
Biochemical Pharmacology (2016) Vol. 110-111, pp. 92-108
Closed Access | Times Cited: 18
GABAA receptor polymorphisms in alcohol use disorder in the GWAS era
M. Koulentaki, Elias Kouroumalis
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1845-1865
Closed Access | Times Cited: 17
Attenuation of dopamine‐induced GABA release in problem gamblers
Arne Møller, Kristine Rømer Thomsen, David J. Brooks, et al.
Brain and Behavior (2019) Vol. 9, Iss. 3
Open Access | Times Cited: 17
Preserved expressive language as a phenotypic determinant of Mosaic Angelman Syndrome
Robert P. Carson, Lynne M. Bird, Anna K. Childers, et al.
Molecular Genetics & Genomic Medicine (2019) Vol. 7, Iss. 9
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top